Biocon Limited has informed the Exchange regarding a press release dated May 13, 2024, titled "Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda�� (Liraglutide) in Mexico with Medix".
Biocon Limited has informed the Exchange regarding a press release dated May 13, 2024, titled "Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda�� (Liraglutide) in Mexico with Medix".